TY - JOUR
T1 - Laser acupuncture for depression : a randomised double blind controlled trial using low intensity laser intervention
AU - Quah-Smith, Im
AU - Smith, Caroline
AU - Crawford, John D.
AU - Russell, Janice
PY - 2013
Y1 - 2013
N2 - Introduction: Trials of acupuncture for the treatment of depression have produced mixed results. We examined the effectiveness of laser acupuncture compared with placebo acupuncture for the treatment of major depression. Methods: A randomised, double blinded, placebo controlled trial was conducted in Sydney, Australia. Participants aged 18–50 years with DSM-IV major depressive disorder were eligible to join the study. Forty-seven participants were randomised to receive laser acupuncture or placebo laser at acupoints LR14, CV14, LR8, HT7 and KI3. The intervention was administered twice a week for 4 weeks and once a week for another four weeks, for a total of 12 sessions. The primary outcome assessed the change in severity of depression using the Hamilton-Depression Rating Scale(HAM-D),and secondary outcomes assessed the change in severity of depression using the Quick Inventory for Depression-Self Reporting (QID-SR), the Quick Inventory for Depression-Clinician (QIDS-CL), with outcomes assessed at eight weeks. The treatment response (greater than 50%improvement in HAM-D) andremission (HAM-Do8) were analysed. Results: At eight weeks participants showed greater improvement in the active laser group on the primary and clinician-rated secondary outcome measures (HAM-D (mean 9.28(SD6.55)vs. mean 14.14 (SD 4.78 p<0.001); QIDS-CL (mean 8.12 (SD6.61 versus 12.68 (mean SD3.77)) p<0.001).The self-report QIDS-SR scores improved in both groups but did not differ significantly between the groups. In the active laser group, QIDS-SR scores remained significantly lower than base line at 3months follow-up. Response rates (active laser, placebo laser) on ITT (intention to treat)analyses were 72.0% and 18.2% (p<0.001), respectively. Remission rates on ITT analyses (active laser, placebo laser) were 56.0% and 4.5% (p<0.001). Transient fatigue was the only adverse effect reported. Limitations: There was no follow-up for the placebo group at one and 3months. Conclusion: Laser acupuncture showed a clinically and statistically significant benefit with reducing symptoms of depressionon objective measures.
AB - Introduction: Trials of acupuncture for the treatment of depression have produced mixed results. We examined the effectiveness of laser acupuncture compared with placebo acupuncture for the treatment of major depression. Methods: A randomised, double blinded, placebo controlled trial was conducted in Sydney, Australia. Participants aged 18–50 years with DSM-IV major depressive disorder were eligible to join the study. Forty-seven participants were randomised to receive laser acupuncture or placebo laser at acupoints LR14, CV14, LR8, HT7 and KI3. The intervention was administered twice a week for 4 weeks and once a week for another four weeks, for a total of 12 sessions. The primary outcome assessed the change in severity of depression using the Hamilton-Depression Rating Scale(HAM-D),and secondary outcomes assessed the change in severity of depression using the Quick Inventory for Depression-Self Reporting (QID-SR), the Quick Inventory for Depression-Clinician (QIDS-CL), with outcomes assessed at eight weeks. The treatment response (greater than 50%improvement in HAM-D) andremission (HAM-Do8) were analysed. Results: At eight weeks participants showed greater improvement in the active laser group on the primary and clinician-rated secondary outcome measures (HAM-D (mean 9.28(SD6.55)vs. mean 14.14 (SD 4.78 p<0.001); QIDS-CL (mean 8.12 (SD6.61 versus 12.68 (mean SD3.77)) p<0.001).The self-report QIDS-SR scores improved in both groups but did not differ significantly between the groups. In the active laser group, QIDS-SR scores remained significantly lower than base line at 3months follow-up. Response rates (active laser, placebo laser) on ITT (intention to treat)analyses were 72.0% and 18.2% (p<0.001), respectively. Remission rates on ITT analyses (active laser, placebo laser) were 56.0% and 4.5% (p<0.001). Transient fatigue was the only adverse effect reported. Limitations: There was no follow-up for the placebo group at one and 3months. Conclusion: Laser acupuncture showed a clinically and statistically significant benefit with reducing symptoms of depressionon objective measures.
KW - depression
KW - laser acupuncture
KW - randomised controlled trial
UR - http://handle.uws.edu.au:8081/1959.7/524611
U2 - 10.1016/j.jad.2012.11.058
DO - 10.1016/j.jad.2012.11.058
M3 - Article
SN - 0165-0327
VL - 148
SP - 179
EP - 187
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -